期刊文献+

基质金属蛋白酶基因多态性与原发性高血压伴颈动脉粥样病变相关性研究 被引量:12

Association between polymorphisms of matrix metalloproteinases and essential hypertension complicated with carotid atherosclerosis
原文传递
导出
摘要 目的:探讨基质金属蛋白酶(matrix metalloproteinase,MMP)与原发性高血压(essential hypertension,EH)伴颈动脉粥样硬化(carotid atherosclerosis,CAS)的关系。方法:EH患者488例,汉族276例,维族212例,采用聚合酶链反应-限制性片断长度多态性技术测定MMPs基因多态性,依据是否存在颈动脉粥样病变分为CAS组293例和颈动脉内膜正常组(NS组)195例。检测各组血压、血脂水平,分别比较各组基因型频率及不同基因型发生EH的风险,分析EH伴CAS的可能危险因素。结果:(1)MMP-2TT基因型、T等位基因频率和MMP-36A/6A基因型、6A等位基因频率在CAS组高于NS组,差异有统计学意义(P<0.05)。(2)汉族MMP-2-735CT+TT和MMP-3-11716A/6A联合基因型优势比增加;维族MMP-2-735CT+TT和MMP-3-11716A/6A联合基因型优势比降低。(3)回归分析显示MMP-2C-735T基因型是维、汉族EH伴CAS的独立危险因素,MMP-3-11715A/6A基因型是汉族EH伴CAS的独立危险因素(P<0.05),与MMP-2具协同效应。结论:MMP-2和MMP-3在人群中的分布存在民族差异;MMP-2-735T等位基因增加了EH患者伴发CAS的风险,MMP-3-11716A等位基因增加了汉族EH患者伴发CAS的风险。 Objective To investigate the relationship between the polymorphisms of matrix metalloproteinases and essential hypertension complicated with carotid atherosclerosis.Methods A total of 488 patients with essential hypertension,including 276 Han and 212 Uygur patients,were divided into two groups,CAS group (essential hypertension with carotid atherosclerosis,n=293) and NS group(essential hypertension without carotid atherosclerosis,n=195).The genotypes were detected with PCR-RFLP technique.The blood pressure and serum lipid levels were determined and the genotypic frequency and the odds ratio (OR) were compared between two groups to study the possible risk factors for carotid atherosclerosis in patients with essential hypertension.Results (1)The frequencies of matrix metalloproteinase-2 TT genotype and T allele and the frequencies of matrix metalloproteinase-3 6A/6A genotype and 6A allele in CAS group were higher than those in NS group(P0.05).(2) The matrix metalloproteinase-2 -735 CT+TT allele and matrix metalloproteinase-3 -1171 6A/6A genotypes had an decreased OR in Han patients and a decreased OR in Uygur patients.(3) The binary logistic regression analysis showed that matrix metalloproteinase-2 C-735T genotypes were the risk factors for carotid atherosclerosis in both Han and Uygur patients with essential hypertension.And matrix metalloproteinases-3 -1171 5A/6A homogeneses were the risk factors for carotid atherosclerosis in Han patients with essential hypertension(P0.05),which had synergism with matrix metalloproteinase.Conclusion Han and Uygur patients have different distribution of matrix metalloproteinase-2 and -3.Matrix metalloproteinase-2 -735 T allele increases the risk for carotid atherosclerosis in both Han and Uygur patients with essential hypertension.Matrix metalloproteinase-2 -1171 6A allele increases the risk for carotid atherosclerosis in Han patients with essential hypertension.
出处 《中华实用诊断与治疗杂志》 2011年第2期117-120,共4页 Journal of Chinese Practical Diagnosis and Therapy
基金 乌鲁木齐市科学技术项目(Y05331001) 新疆维吾尔自治区心血管病研究重点实验室开放课题(XJDX0903-2009-06)
关键词 原发性高血压 基质金属蛋白酶 基因多态性 颈动脉粥样硬化 Essential hypertension matrix metalloproteinases polymorphism atherosclerosis
  • 相关文献

参考文献17

  • 1Newby A C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atheroselerotic plaque rupture [J]. Physiol Rev,2005,85(1) :1 -31.
  • 2中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版全文).高血压杂志,2005,13:1-36.
  • 3邹艳秋 戈晓华.颈部动脉超声多普勒实用手册[M].北京:学苑出版社,1999,6..
  • 4Vasku A, Goldbergovd M, Izakovicova Holla L, et at. Ahaplotype constituted of four MMP-2 promoter polymorphisms( 1575G/A, -1306C/T, -790T/G and 735C/T) is associated with coronary triple vessel disease[J]. Matrix Biol, 2004,22 (7) : 585.
  • 5Armstrong C, Abilleira S, Sitzer M, et al. Polymorphisms in MMP family and TIMP genes and carotid artery intima media thickness[J]. Stroke,2007,38(11) : 2895-2899.
  • 6涂悦,周欣,姚旻,朱勇,庞伟,李玉明.广谱基质金属蛋白酶抑制剂对高血压性脑卒中影响的实验研究[J].中华高血压杂志,2006,14(9):730-734. 被引量:5
  • 7Kuzuya M, Kanda S, Sasaki T, et al. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia[J].Circulation, 2003,108 ( 11 ): 1375- 1381.
  • 8宋亚辉,陈昭喆.卡维地洛对充血性心力衰竭大鼠心肌间质基质金属蛋白酶-2表达的干预作用[J].实用诊断与治疗杂志,2007,21(7):512-514. 被引量:1
  • 9Sluijter J P, Pulskens W P, Schoneveld A H, et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloporteinases 8 and 9 with vulnerable carotid atherosclerotie lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms[J]. Stroke, 2006,37 (1) :235-239.
  • 10Beranek M, Kolar P, Tsehoplova S, et al. Genetic variations and plasma levels of gelatinase A (matrix metallpproteinase 2) and gelatinase B (matrix metallpproteinase-9) in proliferative diabetic retinopathy[J]. Mol Vis,2008,14:1114 -1121.

二级参考文献41

  • 1Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev, 2005, 85: 1- 31.
  • 2Beaudeux JL, Giral P, Bruckert E, et ol. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clin Chem Lab Med, 2004,42:121-131.
  • 3Beyzade S, Zhang S, Wong Y, et al. Influences of matrix metalloproteinase- 3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol, 2003, 41 : 2130-2137.
  • 4Ye S, Watts GF, Mandalia S, et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progerssion of coronary atherosclerosis. Br Heart J, 1995,73 : 209-215.
  • 5Hirashiki A, Yamada Y, Murase Y, et al. Association of gene polymorphisms with coronary artery disease in low-or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol, 2003, 42 : 1429-1437.
  • 6Zhou X, Huang J, Claen J, et al. Haplotype analysis of the matrix metalloproteinase-3 gene and myocardial infarction in a Chinese Han population. The Beijing Aterosclerosis Study. Thromb Haemost, 2004, 92:867-873.
  • 7Dunleavy L,Beyzade S, Ye S. Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis ,2000,151:587-589.
  • 8Morgan L, Humphries SE. The genetics of stroke. Curr Opin Lipidol, 2005,16 : 193-199.
  • 9Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia ,2005,50:329-339.
  • 10Zoppo GJ, Milner R, Mabuchi T, et al. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke, 2007,38 : 646- 651.

共引文献54

同被引文献121

  • 1尚广芹,赵洪芹,潘旭东.颈动脉重度狭窄导致的脑梗死Hs-CRP水平及意义[J].脑与神经疾病杂志,2008,16(5):588-591. 被引量:2
  • 2Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:435
  • 3王宏利,樊东升,沈扬,孙阿萍,张捷,杨玉杰.颈动脉硬化症与高同型半胱氨酸血症关系的研究[J].中华内科杂志,2005,44(4):258-261. 被引量:68
  • 4张莉峰,刘运海,杨期东,刘青芳.急性脑梗死患者颈动脉粥样硬化斑块的研究[J].卒中与神经疾病,2005,12(3):135-137. 被引量:25
  • 5周炯,王荫华.焦虑抑郁量表评价分析[J].中国心理卫生杂志,2006,20(10):665-665. 被引量:85
  • 6陈彦芳.CCMD-3中国精神障碍分类与诊断标准[M].3版.济南:山东科学技术出版社,2001:87-90.
  • 7Dickens C, McGowan L, Percival C, et al. New onset depression following myocardial infarction predicts cardiac mortality[J]. Psychosom Med,2008,70(4) :450-455.
  • 8Steven R E, Pharm D, Brett C W, et al. Relationship between symptoms and health-related quality of life in patients treated for hypertension[J]. Pharmacotherapy, 2004,24 (3) : 344-350.
  • 9Humphreys D, Schlesinger L, Lopez M, et al. Interleukin-6 production and deregulation of the hypothalamic-pituitary- adrenal axis in patients with major depressive disorders[J]. Endocrine,2006,30(3) :371-376.
  • 10Donato M, Annunzio V, Buchholz B, et al. Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning[J]. Exp Physiol, 2010,95 (2) : 74-81.

引证文献12

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部